Biomedical Science Letters (대한의생명과학회지)

The Korean Society for Biomedical Laboratory Sciences (대한의생명과학회)
권호 표지

The Serum Concentrations of YKL-40, IL-6, and TNF-${\alpha}$ in Retired Workers Exposed to Inorganic Dusts

  • Received : 2014.02.02
  • Accepted : 2014.03.29
  • Published : 2014.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Occupational long-term exposure to inorganic dusts may cause a variety of lung diseases such as pneumoconiosis and chronic obstructive pulmonary disease (COPD). Diagnosis of pneumoconiosis and COPD, however, is currently dependent on radiological findings and pulmonary test, which are both late diagnostic tools. Therefore, there is a need to identify novel biomarkers in pneumoconiosis and COPD. Hence, in this current study we investigated the serum concentrations of YKL-40, interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-${\alpha}$) as biomarkers for pneumoconiosis and COPD in 161 retired male workers exposed to inorganic dusts. The serum concentration of YKL-40 was significantly increased with age, pneumoconiosis, and airflow limitation. The serum concentration of IL-6 was significantly higher in airflow limitation. These results suggest that serum concentration of YKL-40 is associated with age, pneumoconiosis, and airflow limitation. Also, serum concentration of IL-6 is associated with airflow limitation.

Keywords

References

  1. Agusti AG, Noguera A, Sauleda J, Sala E, Pons J, Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J. 2003. 21: 347-360. https://doi.org/10.1183/09031936.03.00405703
  2. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009. 33: 1165-1185. https://doi.org/10.1183/09031936.00128008
  3. Brochner CB, Johansen JS, Larsen LA, Bak M, Mikkelsen HB, Byskov AG, Andersen CY, Mollgard K. YKL-40 is differentially expressed in human embryonic stem cells and in cell progeny of the three germ layers. J Histochem Cytochem. 2012. 60: 188-204. https://doi.org/10.1369/0022155411433331
  4. Brusasco V, Crapo R, Viegi G. Series "ATS/ERS Task Force: Standardisation of lung function testing. Eur Respir J. 2005. 26: 319-338. https://doi.org/10.1183/09031936.05.00034805
  5. Chupp GL, Lee CG, Jarjour N, Shim YM, Holm CT, He S, Dziura JD, Reed J, Coyle AJ, Kiener P, Cullen M, Grandsaigne M, Dombret MC, Aubier M, Pretolani M, Elias JA. A chitinaselike protein in the lung and circulation of patients with severe asthma. N Engl J Med. 2007. 357: 2016-2027. https://doi.org/10.1056/NEJMoa073600
  6. Di Francia M, Barbier D, Mege JL, Orehek J. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1994. 150: 1453-1455. https://doi.org/10.1164/ajrccm.150.5.7952575
  7. Elias JA, Zitnik RJ. Cytokine-cytokine interactions in the context of cytokine networking. Am J Respir Cell Mol Biol. 1992. 7: 365-367. https://doi.org/10.1165/ajrcmb/7.4.365
  8. Ferrari R, Tanni SE, Caram LM, Correa C, Correa CR, Godoy I. Three-year follow-up of Interleukin 6 and C-reactive protein in chronic obstructive pulmonary disease. Respir Res. 2013. 20: 14-24.
  9. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004. 59: 574-580. https://doi.org/10.1136/thx.2003.019588
  10. Gosset P, Lassale P, Vanhee D, Wallaert C, Aerts C, Voisin C, Tonne AB. Production of tumor necrosis factor alpha and interleukin-6 by human macrophages exposed in vitro to coal mine dust. Am J Resp Cell Mol Biol. 1991. 5: 431-436. https://doi.org/10.1165/ajrcmb/5.5.431
  11. Guerra S, Halonen M, Sherrill DL, Venker C, Spangenberg A, Carsin AE, Tarès L, Lavi I, Barreiro E, Martinez-Moratalla J, Urrutia I, Sunyer J, Antó JM, Martinez FD. The relation of circulating YKL-40 to levels and decline of lung function in adult life. Respir Med. 2013. 107: 1923-1930. https://doi.org/10.1016/j.rmed.2013.07.013
  12. Gulumian M, Borm PJ, Vallyathan V, Castranova V, Donaldson K, Nelson G, Murray J. Mechanistically identified suitable biomarkers of exposure, effect, and susceptibility for silicosis and coal-worker's pneumoconiosis: a comprehensive review. J Toxicol Environ Health B Crit Rev. 2006. 9: 357-395. https://doi.org/10.1080/15287390500196537
  13. Hashimoto S, Suzuki T, Dong H-Y, Yamazaki N, matsushima K. Serial analysis of gene expression in human monocytes and macrophages. Blood. 1999. 94: 837-844.
  14. Holmgaard DB, Mygind LH, Titlestad IL, Madsen H, Pedersen SS, Johansen JS, Pedersen C. Plasma YKL-40 and all-cause mortality in patients with chronic obstructive pulmonary disease. BMC Pulm Med. 2013. 13: 77. https://doi.org/10.1186/1471-2466-13-77
  15. ILO. Guidelines for the use of the ILO international classification of radiographs of pneumoconiosis. 2002. Geneva, International labor Organization.
  16. Johansen JS. Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer. Dan Med Bull. 2006. 53: 172-209.
  17. Johansen JS, Jensen BV, Roslind A, Nielsen D, Price PA. Serum YKL-40, a new prognostic biomarker in cancer patients? Rev Cancer Epidemiol Biomarkers Prev. 2006. 15:194-202. https://doi.org/10.1158/1055-9965.EPI-05-0011
  18. Johansen JS, Bojesen SE, Mylin AK, Frikke-Schmidt R, Price PA, Nordestgaard BG. Elevated plasma YKL-40 predicts increased risk of gastrointestinal cancer and decreased survival after any cancer diagnosis in the general population. J Clin Oncol. 2009. 27: 572-578. https://doi.org/10.1200/JCO.2008.18.8367
  19. Kawada M, Seno H, Kanda K, Nakanishi Y, Akitake R, Komekado H, Kawada K, Sakai Y, Mizoguchi E, Chiba T. Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis in colorectal cancer. Oncogene. 2012. 31: 3111-3123. https://doi.org/10.1038/onc.2011.498
  20. Korthagen NM, van Moorsel CH, Barlo NP, Ruven HJ, Kruit A, Heron M, van den Bosch JM, Grutters JC. Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis. Respir Med. 2011. 105: 106-113. https://doi.org/10.1016/j.rmed.2010.09.012
  21. Lasky JA, Ortiz LA, Brody AR. Lung injury-mechanisms, pathophysiology, and therapy: Mediators and mechanisms in chronic lung injury and fibrosis (Notter, RH., et al. Eds). 2005. Taylor & Francis Group, FL, pp. 175-226.
  22. Lee CG, Da Silva CA, Dela Cruz CS, Ahangari F, Ma B, Kang MJ, He CH, Takyar S, Elias JA. Role of chitin and chitinase/ chitinase-like proteins in inflammation, tissue remodeling, and injury. Annu Rev Physiol. 2011. 73: 479-501. https://doi.org/10.1146/annurev-physiol-012110-142250
  23. Lee CG, Hartl D, Lee GR, Koller B, Matsuura H, Da Silva CA, Sohn MH, Cohn L, Homer RJ, Kozhich AA, Humbles A, Kearley J, Coyle A, Chupp G, Reed J, Flavell RA, Elias JA. Role of breast regression protein 39 (BRP-39)/chitinase 3- like-1 in Th2 and IL-13-induced tissue responses and apoptosis. J Exp Med. 2009. 206: 1149-1166. https://doi.org/10.1084/jem.20081271
  24. Lee JS, Shin JH, Lee JO, Lee WJ, Hwang JH, Kim JH, Choi BS. Blood levels of IL-1$\beta$, IL-8, TNF-$\alpha$, and MCP-1 in pneumoconiosis patients exposed to inorganic dusts. Toxicol Res. 2009. 25: 217-224. https://doi.org/10.5487/TR.2009.25.4.217
  25. Lee JS, Shin JH, Lee JO, Lee KM, Kim JH, Choi BS. Serum levels of interleukin-8 and tumor necrosis factor-alpha in coal workers' pneumoconiosis: One-year follow-up study. Safety and health at Work. 2010. 1: 69-79. https://doi.org/10.5491/SHAW.2010.1.1.69
  26. Letuve S, Kozhich A, Arouche N, Grandsaigne M, Reed J, Dombret MC, Kiener PA, Aubier M, Coyle AJ, Pretolani M. YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages. J Immunol. 2008. 181: 5167-5173. https://doi.org/10.4049/jimmunol.181.7.5167
  27. Nielsen AR, Plomgaard P, Krabbe KS, Johansen JS, Pedersen BK. IL-6, but not TNF-alpha, increases plasma YKL-40 in human subjects. Cytokine. 2011. 55: 152-155. https://doi.org/10.1016/j.cyto.2011.03.014
  28. Nishikawa KC, Millis AJT. gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells. Exp Cell Res. 2003. 287: 79-87. https://doi.org/10.1016/S0014-4827(03)00069-7
  29. Razzaque MS, Taguchi T. Pulmonary fibrosis: cellular and molecular events. Pathol Int. 2003. 53: 133-145. https://doi.org/10.1046/j.1440-1827.2003.01446.x
  30. Renkema GH, Boot RG, Au FL, Donker-Koopman WE, Strijland A, Muijsers AO, Hrebicek M, Aerts JM. Chitotriosidase, a chitinase, and the 39-kDa human cartilage glycoprotein, a chitin-binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophages. Eur J Biochem. 1998. 251: 504-509. https://doi.org/10.1046/j.1432-1327.1998.2510504.x
  31. Reuben JS, Guo RF, Ward PA. Oxygen/Nitrogen radicals-Lung injury and disease: Mediators of lung inflammation-Role of reactive oxygen and nitrogen species (Vallyathan et al., Ed.). 2004. Marcel Deckker, NewYork, pp. 91-110.
  32. Sakazaki Y, Hoshino T, Takei S, Sawada M, Oda H, Takenaka S, Imaoka H, Matsunaga K, Ota T, Abe Y, Miki I, Fujimoto K, Kawayama T, Kato S, Aizawa H. Overexpression of chitinase 3-like 1/YKL-40 in lung-specific IL-18-transgenic mice, smokers and COPD. PLoS One. 2011. 6: e24177. https://doi.org/10.1371/journal.pone.0024177
  33. Schins RP, Borm PJ. Mechanisms and mediators in coal dust induced toxicity: a review. Ann Occup Hyg. 1999. 43: 7-33.
  34. Vallyathan V, Goins M, Lapp LN, Pack D, Leonard S, Shi X, Castranova V. Changes in bronchoalveolar lavage indices associated with radiographic classification in coal miners. Am J Respir Crit Care Med. 2000. 162: 958-965. https://doi.org/10.1164/ajrccm.162.3.9909074
  35. Vanhee D, Gosset P, Boitelle A, Wallaert B, Tonnel AB. Cytokines and cytokine network in silicosis and coal workers' pneumoconiosis. Eur Respir J. 1995. 8: 834-842.
  36. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013. 187: 347-365. https://doi.org/10.1164/rccm.201204-0596PP
  37. Wouters EF, Groenewegen KH, Dentener MA, Vernooy JH. Systemic inflammation in chronic obstructive pulmonary disease: the role of exacerbations. Proc Am Thorac Soc. 2007. 4: 626-634. https://doi.org/10.1513/pats.200706-071TH
  38. Yende S, Waterer GW, Tolley EA, Newman AB, Bauer DC, Taaffe DR, Jensen R, Crapo R, Rubin S, Nevitt M, Simonsick EM, Satterfield S, Harris T, Kritchevsky SB. Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects. Thorax. 2006. 61: 10-16.
  39. Zhai R, Liu G, Ge X, Bao W, Wu C, Yang C, Liang D. Serum levels of tumor necrosis factor-alpha (TNF-$\alpha$), interleukin-6 (IL-6), and their soluble receptors in coal workers pneumoconiosis. Respir Med. 2002. 96: 829-834. https://doi.org/10.1053/rmed.2002.1367